- Release Date: 07/08/24 09:08
- Summary: First Patient Treatment in the U.S. in the VISABL-AFL Trial
- Price Sensitive: Yes
- Download Document 231.49KB
- Forums
- ASX - By Stock
- IMR
- Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial
IMR
imricor medical systems inc.
Add to My Watchlist
3.28%
!
$1.58

Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.58 |
Change
0.050(3.28%) |
Mkt cap ! $504.7M |
Open | High | Low | Value | Volume |
$1.52 | $1.58 | $1.49 | $217.4K | 140.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8000 | $1.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8000 | 1.540 |
1 | 3000 | 1.485 |
1 | 2000 | 1.480 |
1 | 1500 | 1.470 |
2 | 1417 | 1.410 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 20000 | 1 |
1.590 | 10000 | 1 |
1.650 | 2000 | 1 |
1.700 | 10000 | 1 |
1.710 | 5000 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
IMR (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online